Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutricia PreOp is a clear, non-carbonated, lemon-flavored carbohydrate-rich drink (12.5% carbohydrate, primarily maltodextrin) designed for the preoperative management of patients. It is intended to be consumed up to 2 hours before the induction of anesthesia to transition the patient from a fasted to a fed state. This metabolic preparation aims to reduce preoperative thirst, hunger, and anxiety, while attenuating the metabolic stress response to surgery, specifically postoperative insulin resistance. As a key component of Enhanced Recovery After Surgery (ERAS) protocols, it is used to improve patient well-being and clinical outcomes. Recent clinical research (e.g., NCT03886389) has also explored its metabolic impact on specific conditions like breast cancer, where it may influence tumor proliferation and endocrine markers in estrogen receptor-positive subgroups.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutricia PreOp.